| Pharmaceutical active ingredients: |
| Trihexyphenidyl Hydrochloride |
| Available forms, composition and doses of Aparkane: |
| Tablets; Oral; Trihexyphenidyl Hydrochloride 2 mgTablets; Oral; Trihexyphenidyl Hydrochloride 5 mg |
| Aparkane medical category: |
| Human:Anticholinergic agentsAntiparkinsonian agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04AA01 - Trihexyphenidyl |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ICN Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Triphenidyl | Trihexyphenidyl | Unidentified Pharmaceutical Company |
| Zoxol | Trihexyphenidyl | Osmed Formulations |
| ACA | Trihexyphenidyl Hydrochloride | Atlantic Laboratories |
| Acamed | Trihexyphenidyl Hydrochloride | Medifive Pharma |
| Anti-Spas | Trihexyphenidyl Hydrochloride | Sanofi-Aventis |
| Apo-Trihex | Trihexyphenidyl Hydrochloride | Apotex; Hind Wing; Pharmaforte |
| Arkine | Trihexyphenidyl Hydrochloride | Pyridam |
| Artandyl | Trihexyphenidyl Hydrochloride | Synco |
| Artane | Trihexyphenidyl Hydrochloride | Sanofi-Aventis; AHP Schweiz; Institute of Pharmaceutical Research and Technology; Lederle; Neopharm, Israel; Sigma Pharmaceuticals; Teofarma; Torrex Pharma; U.S. Summit; Wyeth |
| Artane Sequels | Trihexyphenidyl Hydrochloride | Sanofi-Aventis |